To investigate how urogenital infections influence the discontinuation rate of SGLT2i medications in patients with Type 2 diabetes.
Conducted a matched cohort study using population-based data.
Included patients with Type 2 diabetes who initiated SGLT2i.
Analyzed the incidence of SGLT2i discontinuation following UTIs and GTIs.
Patients experiencing a UTI or GTI had higher rates of SGLT2i discontinuation.
The elevated frequency indicates a significant association between infections and treatment discontinuation.
Abstract
Patients with Type 2 diabetes who initiate SGLT2i and experience a UTI or GTI within the following year have an elevated frequency of subsequent SGLT2i discontinuation.
KI fragen
Like
Bookmark
Share
View Full Paper
KI fragen
Like
Bookmark
Share
View Full Paper
Discontinuation of SGLT2i After a Urogenital Infection: A Population‐Based Matched Cohort Study of Patients With Type 2 Diabetes | Synapse